Transcription of Chapter 1 Longitudinal Data Analysis
1 Themostcommonmedicalresearch designsis a \pre-post"studyinwhich a singlebaselinehealthstatusmeasurement is obtained,aninterven-tionis administered,anda singlefollow-upmeasurement is theoutcomemeasurement canbe as-sociatedwiththechangein example,if somesubjectsaregivenplacebo whileothersaregivenanactive drug,thetwogroupscanbe comparedto seeif thechangein theoutcomeis di erent forthosesubjectswhoareactivelytreatedas comparedto viewed as thesimplestformof a prospective nition: Alongitudinalstudyrefersto aninvestigationwherepartici-pant outcomesandpossiblytreatments or exposuresarecollectedat longitudinalstudygenerallyyieldsmultiple or \repeated"measurementsoneach example,HIVpatients may be followedover timeandmonthlymeasuressuch as CD4counts,or viralloadarecollectedto charac-terizeimmunestatusanddiseaseburde nrespectively.
2 Such repeatedmea-suresdataarecorrelatedwithin subjectsandthus secondimportant outcomethatis commonlymeasuredin a longitudinalstudyis thetimeuntil a key clinicalevent such as diseaserecurrenceor LONGITUDINALDATA ANALYSISA nalysisof event timeendpoints is thefocusofsurvivalanalysiswhich iscoveredin Chapter ??.Longitudinalstudiesplay a key rolein epidemiology, clinicalresearch, characterizenormalgrowthandaging,to assessthee ectof riskfactorsonhumanhealth,andto evaluatethee ectivenessof a greatdealof e ortbuto erseveralbene- tsinclude:Bene tsof recorded.
3 A prospective longitudinalstudymea-suresthenewoccuranc eof diseaseonsetcanbecorrelatedwithrecent changesin patient exposure. In a prospective studypartic-ipants canhave theirexposurestatusrecordedat recalltheirexposure(a formofmeasurement error).In additionthetemporalorderof exposuresandoutcomesis individualchangein outcomes. A keystrengthof alongitudinalstudyis theability to measurechangein outcomesand/orexposureat to observe individualpatternsof timee ects:Cohort,Period, Age. Whenstudyingchangeover timetherearemany timescalesto birthsuch as 1945or 1963,periodis thecurrent timesuchas2003,andageis (period - cohort),forexample58= 2003-1945,and40 = longitudinalstudywithmeasurements at timest1; t2; : : : tncansimultaneouslycharacterizemultiplet imescalessuch asageandcohorte ectsusingcovariatesderivedfromthecalenda rtimeof visitandtheparticipant'sbirthyear:theage of subjectiat timetjis ageij= (tj birthi); andtheircohortis simplycohortij= [1996]discussesage,period, andcohorte ectsin theanalysisof forcohorte ects.
4 Ina cross-sectionalstudythecomparisonof subgroupsof di erent agescombinesthee ectsof agingandthee ectsof di erent , comparisonof outcomesmeasuredin 2003among58yearoldsubjectsandamong40year oldsubjectsre ectsboththefactthatthegroupsdi erby 18years(aging)andthefactthatthesubjectsw erebornin di erent example,thepublichealthinterventionssuch as vaccinationsavailablefora childunder10yearsof agemay diferduring1945-1955as comparedto thepreventive interventionsexperiencedin longitudinalstudythecohortunderstudyis xedandthus changesin timearenotconfoundedby cohortdi longitudinaldataanalysisopportunitiesin respiratoryepi-demiologyis presentedin WeissandWare[1996].
5 Thebene tsof a :Challengesof Thereis theriskof biasdueto incompletefollow-up,or \drop-out"of subjectsthatarefollowed totheplannedendof studydi erfromsubjectswhodiscontinue follow-upthena naive analysismay providesummariesthatarenotrepresenta-tiv e of correlated data . Statisticalanalysisof longitudinaldatarequiresmethods thatcanproperlyaccount fortheintra-subjectcor-relationof such correlationis ignoredtheninferencessuch as statisticaltestsor con denceintervalscanbe Althoughlongitudinaldesignso ertheop-portunity to associatechangesin exposurewithchangesin theoutcomeof interest,thedirectionof causality canbe complicatedby \feedback" example,in anobserva-tionalstudyof thee ectsof a drugonspeci cindicatorsof health.
6 A patient'scurrent healthstatusmay in uencethedrugexposureordosagereceivedin cinterestliesin thee ectof medicationonhealth,thisexamplehasrecipro calin uence4 CHAPTER1. LONGITUDINALDATA Analysis betweenexposureandoutcomeandposesanalyti caldi culty whentryingto separatethee ectof medicationonhealthfromthee thissubsectionwe give someexamplesof longitudinalstudiesandfocusontheprimarys cienti cmotivationin additionto keyoutcomeandcovariatemeasurements.( )ChildAsthmaManagement Program(CAMP){ In thisstudychildrenarerandomizedto di erent asthmamanagement multicenterclinicaltrialwhoseprimaryaimi s theevaluationof thelong-terme ectsof dailyinhaledanti-in ammatorymedicationuseonasthmastatusandlu nggrowthin childrenwithmildto moderateashtma(Sze eret ).}
7 Outcomesincludecontinuousmeasuresof pulmonaryfunctionandcatergoricalindicato rsof ambient pollutionandtheprevalenceof anenvironmentalexposurerequiresspeci cationof a lagbetweentheday of exposureandtheresultinge theairpollutionliteratureshortlagsof 0 to 2 days arecommonlyused(Sametet ;Yu et ).For boththeevaluationof treatmentandexposureto environmentalpollutionthescienti cquestionsfocusontheassociationbetweenan exposure(treatment, pollution) outcomesis of secondaryinterest,butmustbe acknowledgedto obtainvalidstatisticalinference.( )CysticFibrosisandPulmonaryFunction{ TheCysticFibro-sisFoundationmaintainsa registryof longitudinaldataforsubjectswithcystic asthe1-secondforcedexpiratoryvolume(FEV1 )}
8 Andpatient healthindicatorssuch as infectionwithPseudomonasaeruginosahave cobjective is to characterizethenaturalcourseof thediseaseandto estimatetheaveragerateof declinein determinewhethermeasuredpatient characteristicssuch asgenderandgenotype correlatewithdiseaseprogression,or withanincreasedrateof declinein a typicalobservationaldesignwherethelongit udinalnatureof thedataareimportant changein healthoutcomessuch as lungfunction.( )TheMulti-CenterAIDSC ohortStudy(MACS){ TheMACS studyenrolledmorethan3,000menwhowereat riskforacquisitionof HIV1(Kaslow et ).}
9 Thisprospective cohortstudyobservedN= 479inci-dent HIV1infectionsandhasbeenusedto particular,thisstudyhasdemonstratedthee ectof HIV1infectiononindicatorsof immunologicfunctionsuch as cquestionis whetherbaselinecharacteristicssuchas viralloadmeasuredimmediatelyafterserocon versionareassociatedwitha poor patient prognosisas indicatedby a greaterrateof declinein usethesedatato illustrateanalysisapproachesforcontinuou slongitudinalresponsedata.( )HIVNETI nformedConsent Substudy{ Numerousreportssug-gestthattheprocessof obtaininginformedconsent in orderto participateinresearch studiesis ,forpreventive HIVvaccinetrialsa prototype informedconsent processwas evaluatedamongN= 4;892subjectsparticipatingin theVaccinePreparednessStudy(VPS).}
10 Approxi-mately20%of subjectswereselectedat randomandasked to participatein amock informedconsent process(Colettiet ).Participant knowledgeof key vaccinetrialconceptswas evalulatedat baselinepriorto theinformedconsent visitwhich occuredduringa special3 month thenassessedforallpar-ticipants at thescheduled6, 12, basiclongitudinalextensionof a ,anda totalscorethatcalculatesthenumber of correctresponsesminusthenumber of subsetof focusonsubjectswhowereconsideredat highriskof HIVacquisitiondueto thischapterwe useYijto denotetheoutcomemeasuredon subjectiat timetij.
